CAMK2G and cancer: However, if the binding partners of pThr253-CaMKII that control cancer cell proliferation, and of pThr286-CaMKII responsible for cancer cell metastasis, can be identified, and inhibitors that selectively block these interactions developed, cancer cell proliferation or metastasis could be selectively inhibited, while leaving the normal brain and heart cell function unimpacted.